Publication details

Amiodaronem indukované postižení plic u pacienta s fibrilací síní

Title in English Amiodarone induced pulmonary toxicity
Authors

HUDEC Martin VYSOČANOVÁ Petra BRÁZDIL Vojtěch POLOCZEK Martin HETMER Martin LITTLE Jiřina DOUBKOVÁ Martina KALA Petr

Year of publication 2021
Type Article in Periodical
Magazine / Source Vnitřní lékařství
MU Faculty or unit

Faculty of Medicine

Citation
Web https://casopisvnitrnilekarstvi.cz/artkey/vnl-202107-0013_amiodarone-induced-pulmonary-toxicity.php
Doi http://dx.doi.org/10.36290/VNL.2021.116
Keywords AIPT; Amiodarone; Amiodarone induced pulmonary toxicity; Amiodarone lung
Description Amiodarone is one of the more frequently used drugs in the treatment of supraventricular and ventricular arrhythmias. Many adverse effects, more or less serious, are associated with its administration. Amiodaron-induced pulmonary toxicity (AIPT) is quite rare but represents one of the most severe adverse effects with high mortality. We present an 80 years old patient, who used amidorane due to paroxysmal atrial fibrillation for several years. Within 3 months, he was repeatedly hospitalized for a bilateral pneumonia. Eventually, AIPT was diagnosed. Early diagnosis, proper therapy of AIPT and changed antiarrhythmic therapy has significantly improved the clinical status of our patient. In this case we demonstrate typical clinical presentations of AIPT as well as the most common diagnostic procedures and recommended treatment methods. Finally, some other commonly used therapeutical options for supraventricular arrhythmias are mentioned. Future options are outlined. © 2021, SOLEN s.r.o.. All rights reserved.

You are running an old browser version. We recommend updating your browser to its latest version.

More info